Overcoming the demands of digital content: Is your pharma content approval system ready for the modern age?Over the last ten years the increase in use of digital content and communication throughout pharma has been Share XOvercoming the demands of digital content: Is your pharma content approval system ready for the modern age?https://pharmaphorum.com/debates-insight-sales-marketing/overcoming-the-demands-of-digital-content-is-your-pharma-content-approval-system-ready-for-the-modern-age/
Acting on the moments that matter to build a brandAll too often pharmaceutical marketing orthodoxy says to focus on just one area – a product’s launch, in Share XActing on the moments that matter to build a brandhttps://pharmaphorum.com/sales-marketing/acting-on-the-moments-that-matter-to-build-a-brand/
Designing behavioural science-based patient support programmesWe all exhibit behaviours that are, at times, irrational, and this presents a major challenge for pharmaceutical companies Share XDesigning behavioural science-based patient support programmeshttps://pharmaphorum.com/sales-marketing/designing-behavioural-science-based-patient-support-programmes/
Adherence – Don’t Remind Me!The benefits of adherent patients are no secret: better outcomes, a more stable treatment pathway and of course Share XAdherence – Don’t Remind Me!https://pharmaphorum.com/sales-marketing/adherence-dont-remind-me/
Intelligent HCP engagement in Europe – what do doctors want?The opportunity to engage with HCPs digitally has never been more prevalent. We are witnessing a desire from Share XIntelligent HCP engagement in Europe – what do doctors want?https://pharmaphorum.com/digital/intelligent-hcp-engagement-europe/
Understanding blockchain – a practical guide for life sciences companiesWithin the life science industry, uptake of blockchain is in the early stages, but with investment levels in Share XUnderstanding blockchain – a practical guide for life sciences companieshttps://pharmaphorum.com/digital/insights-digital/understanding-blockchain-life-sciences/
The innovation challenge: realising the true potential of digitalDigital transformation; it would be easy to assume that it is widespread across the life science industry, and Share XThe innovation challenge: realising the true potential of digitalhttps://pharmaphorum.com/digital/insights-digital/innovation-challenge-true-potential-digital/
How pharma can boost engagement by embracing support networksConnecting with patients has become a central plank in the pharma marketing playbook, but should companies be looking Share XHow pharma can boost engagement by embracing support networkshttps://pharmaphorum.com/patients/insights-patients/how-pharma-can-boost-engagement-by-embracing-support-networks/
The changing face of pharmaceutical launchesThe industry has experienced a sustained period of change since its blockbuster heyday in the 1990s and continues Share XThe changing face of pharmaceutical launcheshttps://pharmaphorum.com/market-access-2/digital-transforming-pharmaceutical-launches/
Remote HCP engagement – still a struggle for life science companiesLife science companies are failing to achieve their full digital potential, particularly when it comes to the use Share XRemote HCP engagement – still a struggle for life science companieshttps://pharmaphorum.com/white-papers/remote-hcps-engagement-life-science/
Medical meetings and what HCPs wantThe healthcare professional (HCP) meeting landscape is evolving, but even as it adjusts to the demands of the Share XMedical meetings and what HCPs wanthttps://pharmaphorum.com/whitepapers/medical-meetings-and-what-hcps-want/
Pharma brand strategy: Transforming lives with rich insightThe mighty power of true insight lays in its ability to turn data into a brand strategy that Share XPharma brand strategy: Transforming lives with rich insighthttps://pharmaphorum.com/whitepapers/pharma-brand-strategy-transforming-lives-with-rich-insight/
